{"name":"Parvus Therapeutics, Inc.","slug":"parvus-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PVT201","genericName":"PVT201","slug":"pvt201","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PVT201","genericName":"PVT201","slug":"pvt201","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPVWdGRTVzOWhMVlJyUkU3eXc2SjFDbl9lbm93VmphbEtwRXBybklIbjB1Njhvdk5KaXdDNkRURXdWaTlySWxaaUFuZVFjZlZPYVR4cWRNRkpzeUlKRjJsYVlUX0pIdWpsTkJRWlJLNm85ZHFZZG9ndHlSRy1xQXFNb3RWX0lpME9SOEJ1VFNCVzREWTA?oc=5","date":"2025-12-17","type":"pipeline","source":"Insightace Analytic","summary":"Novel T-Cell Immunotherapies Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Novel T-Cell Immunotherapies Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQLTBNRkZZXzNsaGhXa3FFMWdDQzFmQTE0di1MRExNcWJ1eHNjRzN2TVVseXlOQzUweWliS2JwUkt1TUcyTG41eHdXQk9WVGYtS2Jfa19ibUxGVmZPZ1VZUUdjLXJrLXNjN0RMMXI0OGFPV0JaVkwzZ2ZpV3JXX1pRNWhMdDVDSE1Ma2tWb2ZrQm1VWndscHk3LXlVTVQ2MVQtWDFnMXhVUkcxUmNSRnQ3TWFDR05jSHhKcml5MVpqN3Y0Y2Rsam9HSnJ6V3lXT18yNk5ZUWpUVXI2UGppX2ZVb0ZPNVBTVDZkT0o2QnF2M2tvaFFGR3Y1UUNqRThjQzlWRXpQYWtRZEVJSDdrTDkzRnFLcHp4N2R1a3FRSWY1TDN0V2g2WFA2a2FSLWFhMVEtOXNNczBpc2FhSmNV?oc=5","date":"2025-11-18","type":"trial","source":"PR Newswire","summary":"Primary Biliary Cholangitis (PBC) Treatment Market to Reach USD 2.72 Billion by 2033, Driven by Next-Generation FXR Agonists & Immunomodulators | DataM Intelligence - PR Newswire","headline":"Primary Biliary Cholangitis (PBC) Treatment Market to Reach USD 2.72 Billion by 2033, Driven by Next-Generation FXR Agon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOZF9Kem1HR3k2eGR3Zk5JQnU5bHRfTW9VZng5VTJwRHFwT2RHS2c3a2dUYXBoSnpEaVl1LUV5ZVM0cVdaSWpnWDVXVWFVRDE1ZHdGMEVxZUFTaXJTclQwZGFBQXBZSVVVTXUyc19iN3czelRoYWJkQzVfTEVXTDRhZDV5OUNlcDRhSERnTHBjblNTN3Zmb1NPT3lEX19pLWJ4YjZKVThFSDYxUGlQY3dNTVg2Y0lycE9yVFFaVkx3Rnh4bW1yYjBjYXZyYWc?oc=5","date":"2025-04-22","type":"deal","source":"BioWorld News","summary":"PVT-401 achieves milestone under Parvus and Abbvie inflammatory bowel disease collaboration - BioWorld News","headline":"PVT-401 achieves milestone under Parvus and Abbvie inflammatory bowel disease collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNaEVldGdicmc4NlBWSXNQNVZ4RGQ2NVlWYW5ITWFZa1c2c016bXEtaGZwcWRMRm1kTi11VlJvME5qZ3VXNVE1cEFpTzU1WksyeWlwOFlieC1WWHpPYXRjemFRbG5nSGdyOGFHeTlwWjZRUUhpNjNhbmwxYk1OSWFhb2xwdk5JMHpJbWdTcUcyaThCUmZnd0pQNVhOWDJqQnpTYUNVQ3pqcHNJeFJrUXo4NHdTSlBkbkx1NHFQbmVGYkotWWFhVS1TLW5Dc3JnaHNjcEp3?oc=5","date":"2025-03-26","type":"deal","source":"Business Wire","summary":"Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash - Business Wire","headline":"Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPM1VqMkd4bW15LW1RM1FTNFEzNHktNWRhM2hXWUpmMkMtRnc0dEdnaUVoYm1lMEpEQlVQSjJZN2M2ZVd5RmNVRUhmTmpvc2k5eFFaZXQycUdONVVkQ0tucGJYNXJOajY1ZE9tczVIZUp5cUZhMjFWaUpSV2ptclN4ZGl6NmVidXc1ZmU0MzYxTUVfWUZveTVzOS16YXpXaUNVS0V6TUM5dFQwT1huMjRnYnJtQWdwMjNxLTNiMUQtSW1odlNFNWREbGY0Q0JvR2ZuZ2ZQajYxazVxQ1BXdnYwamZONEJ0RkNha1M1NGF1djZlZ0NKVGhiVG50RQ?oc=5","date":"2024-11-19","type":"pipeline","source":"PR Newswire","summary":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - PR Newswire","headline":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFAzZUczalBhRkpXU3lpWGl5WC0tQkhvb0xtRDZMckJ1aXFmdzZKckxTX0RIbExmdDV6Z3JKU3cwbXFSMGE0Ql9JeFhFd0hwd2tPZUdYYndtUVBWQ3BDUHI5dGdjaHNEZngyYk83RE1oSzlsd0gtSy1VeFlob1BacXc?oc=5","date":"2021-06-09","type":"pipeline","source":"Avenue Calgary","summary":"How Parvus Therapeutics Inc. Discovered a New Class of Drugs - Avenue Calgary","headline":"How Parvus Therapeutics Inc. Discovered a New Class of Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE00OG8xZy1YZGpQWWN3aXRXVWhOTGVaRUlaZzBUR2duUzRIVV9Sa2lHeU1lYW5qNlZkRURKRFFjUGlUdi1FeU1keTNaNGs4UVJULVMyeG5laTF2ZTR6cWotQ3ZkRHBBNEk5elIwd2NpNFNSNTlVVWc?oc=5","date":"2021-06-07","type":"pipeline","source":"Avenue Calgary","summary":"Meet Four Unicorn Companies Valued at Over $1 Billion in Calgary - Avenue Calgary","headline":"Meet Four Unicorn Companies Valued at Over $1 Billion in Calgary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOOGpGOGEtYlNTeDkxc2JwWmx1cWdLTEYzOHlHWVFRZTZnVVVLclRuZjNpSTVCNktNenN0TGF3dnBGSVoxaS1VRnZfVFpHWkpYa3ptWm1UZVhiZXQ5aG44RVQ3TWRscFVWUlFJUkUzcDI4QlJXZkw5YVZVS2tHbzVWR0o3bnVrSTJCUDgwV2lzamtDbHQ2?oc=5","date":"2019-09-12","type":"deal","source":"BioWorld News","summary":"Anokion acquires its spin-out, raises $40M series B - BioWorld News","headline":"Anokion acquires its spin-out, raises $40M series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOeDVTaExZWXNXX0w0LUQ0REJDc1I5NHlsdmVDb0ZIQ3BfWEVzV2g4MEpSZHFwdy12eERMNjJsdGN5aDhsMWVwenVYc0ZxSWxXLWNHQWxSN0d5OERicVJvdjJ1anBkZmlQUjVBallNR3VTNHM1S1MwZE1QV0JwcktublV3?oc=5","date":"2019-05-16","type":"deal","source":"BioSpace","summary":"Parvus and Genentech Forge Autoimmune Collaboration - BioSpace","headline":"Parvus and Genentech Forge Autoimmune Collaboration","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}